Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

Free Publication Certificate

Vol. 10, Issue 7 (2021)

The efficacy of combination therapy of Ivermectin + Amitraz for successful therapeutic management of canine demodicosis: A case study

Author(s):
Tradhnesh P, Krishnakanth K, Sreelakshmi SS and Deepak Chandran
Abstract:
Canine demodicosis (Demodectic mange) is a skin disease of dogs consisting of greater than normal numbers of Demodex mites. Localized demodicosis is a common mild and benign self-limiting disease. In contrast, generalized demodicosis is a serious and potentially life-threatening disease. Most cases of generalized demodicosis are juvenile in onset and develop in dogs less than 1 year of age. Dogs aged between four months to two years, in which five dogs reported with history of reddish lesion on the body mainly on the face region and showing intense pruritis were selected. Canine demodicosis represents a most perplexing treatment problem all over the world. The present study was aimed to determine the efficiency of combination therapy with subcutaneous injection of Ivermectin weekly intervals for upto 4 weeks, topical application of Amitraz at weekly intervals, immunomodulators orally and antibiotics to prevent secondary Pyoderma.
Pages: 1375-1377  |  264 Views  127 Downloads


The Pharma Innovation Journal
How to cite this article:
Tradhnesh P, Krishnakanth K, Sreelakshmi SS, Deepak Chandran. The efficacy of combination therapy of Ivermectin + Amitraz for successful therapeutic management of canine demodicosis: A case study. Pharma Innovation 2021;10(7):1375-1377.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal


Call for book chapter